DE VITO, ANNACHIARA
DE VITO, ANNACHIARA
Mostra
records
Risultati 1 - 2 di 2 (tempo di esecuzione: 0.0 secondi).
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation
2025 Mussini, C; Giacomelli, A; Quiros-Roldan, E; Mazzotta, V; Di Biagio, A; De Vito, A; Costantini, A; D'Ettorre, G; Giacometti, A; Vergori, A; Tavelli, A; Malagnino, V; Castagna, A; Chester, J; Antinori, A; D'Arminio Monforte, A; Cozzi-Lepri, A; Coppola, N; Icona Foundation Cohort Study For The Icona Foundation Study, Group
Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort
2025 De Vito, A; Tavelli, A; Cozzi-Lepri, A; Giacomelli, A; Rossotti, R; Ponta, G; Bobbio, N; Ianniello, A; Cingolani, A; Madeddu, G; Antinori, A; D'Arminio Monforte, A; Coppola, N; Icona Foundation Study, Group.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation | 1-gen-2025 | Mussini, C; Giacomelli, A; Quiros-Roldan, E; Mazzotta, V; Di Biagio, A; De Vito, A; Costantini, A; D'Ettorre, G; Giacometti, A; Vergori, A; Tavelli, A; Malagnino, V; Castagna, A; Chester, J; Antinori, A; D'Arminio Monforte, A; Cozzi-Lepri, A; Coppola, N; Icona Foundation Cohort Study For The Icona Foundation Study, Group | |
| Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort | 1-gen-2025 | De Vito, A; Tavelli, A; Cozzi-Lepri, A; Giacomelli, A; Rossotti, R; Ponta, G; Bobbio, N; Ianniello, A; Cingolani, A; Madeddu, G; Antinori, A; D'Arminio Monforte, A; Coppola, N; Icona Foundation Study, Group. |